Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofia Ramiro

Showing results (11-20 of 287) with videos related to

Pageof 29
Sort By:
Expert Review of Clinical Immunology|September 11, 2010
RAPID and FAST4WARD trials: certolizumab pegol for rheumatoid arthritisSofia Ramiro, Astrid M van Tubergen, Robert Bm Landewé
Seminars in Arthritis and Rheumatism|April 26, 2021
Peripheral arthritis and higher disease activity lead to more functional impairment in axial spondyloarthritis: Longitudinal analysis from ESPAXIADafne Capelusnik, Sofia Ramiro, Emilce E Schneeberger, et al.
RMD Open|June 7, 2019
Three handy tips and a practical guide to improve your propensity score modelsSytske Anne Bergstra, Alexandre Sepriano, Sofia Ramiro, et al.
Joint Bone Spine|June 24, 2023
Looking through the window of opportunity in axial spondyloarthritis?Diego Benavent, Dafne Capelusnik, Sofia Ramiro, et al.
RMD Open|July 10, 2020
Strategies for the assessment of competences during rheumatology training across Europe: results of a qualitative studyAurélie Najm, Alessia Alunno, Francisca Sivera, et al.
RMD Open|April 1, 2021
COVID-19-induced hyperinflammation, immunosuppression, recovery and survival: how causal inference may help draw robust conclusionsRobert B M Landewé, Sofia Ramiro, Rémy L M Mostard
Rheumatology (Oxford, England)|October 25, 2022
External validation of the alternative Ankylosing Spondylitis Disease Activity Score in three randomized clinical trials of ixekizumabAugusta Ortolan, Sofia Ramiro, Roberta Ramonda, et al.
Rheumatology and Therapy|April 9, 2025
The Impact of IL-17A Inhibition in Rheumatic and Musculoskeletal Diseases: Current Insights and Future ProspectsSofia Ramiro, Georg Schett, Helena Marzo-Ortega, et al.
RMD Open|July 13, 2021
Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inferenceAlexandre Sepriano, Sofia Ramiro, Desirée van der Heijde, et al.
Annals of the Rheumatic Diseases|November 14, 2025
Final validation of the hierarchical framework for outcomes in axial spondyloarthritis: longitudinal determinants of health-related quality of lifeAugusta Ortolan, Désirée van der Heijde, Laure Gossec, et al.
Pageof 29

Showing results (11-20 of 287) with videos related to

Sort By:
Pageof 29
Expert Review of Clinical Immunology|September 11, 2010
RAPID and FAST4WARD trials: certolizumab pegol for rheumatoid arthritisSofia Ramiro, Astrid M van Tubergen, Robert Bm Landewé
Seminars in Arthritis and Rheumatism|April 26, 2021
Peripheral arthritis and higher disease activity lead to more functional impairment in axial spondyloarthritis: Longitudinal analysis from ESPAXIADafne Capelusnik, Sofia Ramiro, Emilce E Schneeberger, et al.
RMD Open|June 7, 2019
Three handy tips and a practical guide to improve your propensity score modelsSytske Anne Bergstra, Alexandre Sepriano, Sofia Ramiro, et al.
Joint Bone Spine|June 24, 2023
Looking through the window of opportunity in axial spondyloarthritis?Diego Benavent, Dafne Capelusnik, Sofia Ramiro, et al.
RMD Open|July 10, 2020
Strategies for the assessment of competences during rheumatology training across Europe: results of a qualitative studyAurélie Najm, Alessia Alunno, Francisca Sivera, et al.
RMD Open|April 1, 2021
COVID-19-induced hyperinflammation, immunosuppression, recovery and survival: how causal inference may help draw robust conclusionsRobert B M Landewé, Sofia Ramiro, Rémy L M Mostard
Rheumatology (Oxford, England)|October 25, 2022
External validation of the alternative Ankylosing Spondylitis Disease Activity Score in three randomized clinical trials of ixekizumabAugusta Ortolan, Sofia Ramiro, Roberta Ramonda, et al.
Rheumatology and Therapy|April 9, 2025
The Impact of IL-17A Inhibition in Rheumatic and Musculoskeletal Diseases: Current Insights and Future ProspectsSofia Ramiro, Georg Schett, Helena Marzo-Ortega, et al.
RMD Open|July 13, 2021
Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inferenceAlexandre Sepriano, Sofia Ramiro, Desirée van der Heijde, et al.
Annals of the Rheumatic Diseases|November 14, 2025
Final validation of the hierarchical framework for outcomes in axial spondyloarthritis: longitudinal determinants of health-related quality of lifeAugusta Ortolan, Désirée van der Heijde, Laure Gossec, et al.
Pageof 29